Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Block Certain Proteins Made by Some Types of Immune System Cells
Completed
Conditions studied: Cancer
In brief
A retrospective, observational study conducted on cancer patients receiving a drug that blocks certain proteins made by some types of immune system cells
Key facts
- Study ID
- NCT03644498
- Run by
- Bristol-Myers Squibb
- People needed
- 1056
- Starts
- 2018-05-02
- Expected to finish
- 2018-10-17
- Last updated by the study team
- 2024-01-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Treatment with a checkpoint inhibitor (CPI)
- Age greater than or equal to 18 years on date of first claim for a CPI
- ICD-9 or ICD-10 code for a malignancy within 180 days prior to the first claim for any CPI, and
- Greater than or equal to 180 days of continuous pharmaceutical and medical benefit enrollment in the database prior to the first claim for any CPI
You may not qualify if…
- Less than 18 years of age
- Other protocol defined inclusion/exclusion criteria could apply
Where it is running
- Local Institution — Princeton, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.